Mary Ellen Salenieks

$108,753.49asBusiness Strategist / Directeur, Stratégie De L'Entreprise

Employed by Cancer Care Ontario / Action Cancer Ontario in 2011, according to Government of Ontario public salary records.

Salary Information

Historical salary and taxable benefits from 2011 to 2011.

YearPositionSalaryBenefitsPerformance
2011
Business Strategist / Directeur, Stratégie De L'Entreprise
$108,753.49
$401.34

The Ontario Sunshine List reports that Mary Ellen Salenieks was paid $108,753.49 in 2011 as Business Strategist / Directeur, Stratégie De L'Entreprise at Cancer Care Ontario / Action Cancer Ontario. 2011 is the first year Mary Ellen Salenieks appeared on the Ontario Sunshine List. In addition to salary, $401.34 in taxable benefits was disclosed for 2011. Cancer Care Ontario / Action Cancer Ontario reports under the Crown Agencies sector of Ontario's public sector salary disclosure.

Top earning Business Strategist / Directeur, Stratégie De L'Entreprises in Cancer Care Ontario / Action Cancer Ontario

NameSalary
MARY ELLEN SALENIEKS$108,753.49
NameSalary
Alon Greener
Manager, Quality Assurance Services / Directeur, Services D'Assurance De La Qualité
$111,024.46
Will Klassen
Product Manager / Directeur De Produit
$110,527.21
Eva Viviano
Manager, Service Management Services / Directeur, Services De Gestion Des Services
$109,877.74
Mohammed N. Chowdhury
Technical Specialist / Spécialiste Technique
$109,209.66
Anna Chiarelli
Senior Scientist / Chercheur Principal
$108,841.32
Mark Mycyk
Manager, Business Intelligence Development-Access To Care / Directeur, Élaboration De L'Intelligence Commerciale, Accès Aux Soins
$108,338.52
Glynis Williams
Director, Service Management Services / Directeur Principal, Services De Gestion Des Services
$107,651.33
Walter Blanco
Product Manager / Directeur De Produit
$106,789.32
Ivan Barsby
Manager, Planning & Program-Access To Care / Directeur, Planification Et Programme, Accès Aux Soins
$106,686.97
Alethea Kewayosh
Aboriginal Lead, Cancer Control / Directeur Aborigène, Lutte Contre Le Cancer
$106,512.85